These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 36828435)

  • 1. Comparison of the Clinical Efficacy and Adverse Events between Intravesical Injections of Platelet-Rich Plasma and Botulinum Toxin A for the Treatment of Interstitial Cystitis Refractory to Conventional Treatment.
    Jhang JF; Yu WR; Kuo HC
    Toxins (Basel); 2023 Feb; 15(2):. PubMed ID: 36828435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravesical injections of platelet-rich plasma is effective and safe in treatment of interstitial cystitis refractory to conventional treatment-A prospective clinical trial.
    Jhang JF; Lin TY; Kuo HC
    Neurourol Urodyn; 2019 Feb; 38(2):703-709. PubMed ID: 30576011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravesical botulinum toxin a injections do not benefit patients with ulcer type interstitial cystitis.
    Lee CL; Kuo HC
    Pain Physician; 2013; 16(2):109-16. PubMed ID: 23511677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated intravesical injections of platelet-rich plasma are effective in the treatment of interstitial cystitis: a case control pilot study.
    Jhang JF; Wu SY; Lin TY; Kuo HC
    Low Urin Tract Symptoms; 2019 Apr; 11(2):O42-O47. PubMed ID: 29265766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated intravesical onabotulinumtoxinA injections are effective in treatment of refractory interstitial cystitis/bladder pain syndrome.
    Kuo HC
    Int J Clin Pract; 2013 May; 67(5):427-34. PubMed ID: 23574103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of efficacy and safety between bladder body and trigonal intravesical onabotulinumtoxina injection in the treatment of interstitial cystitis refractory to conventional treatment-A prospective, randomized, clinical trial.
    Jiang YH; Jhang JF; Lee CL; Kuo HC
    Neurourol Urodyn; 2018 Apr; 37(4):1467-1473. PubMed ID: 29331031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical evidence suggests repeated intravesical application of botulinum toxin A injections may improve treatment efficacy of interstitial cystitis/bladder pain syndrome.
    Shie JH; Liu HT; Wang YS; Kuo HC
    BJU Int; 2013 Apr; 111(4):638-46. PubMed ID: 22943596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modified Botulinum Toxin Type A Injections Improve Symptoms Associated With Interstitial Cystitis/Bladder Pain Syndrome in Women: A Retrospective Cohort Study.
    Wang Y; Zheng J; Li Z; Jiang Y; Yu J; Li S; Chen X
    Urology; 2024 Jul; 189():27-33. PubMed ID: 38710455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravesical onabotulinumtoxinA injections for refractory painful bladder syndrome.
    Chung SD; Kuo YC; Kuo HC
    Pain Physician; 2012; 15(3):197-202. PubMed ID: 22622903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravesical botulinum toxin-A injections reduce bladder pain of interstitial cystitis/bladder pain syndrome refractory to conventional treatment - A prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial.
    Kuo HC; Jiang YH; Tsai YC; Kuo YC
    Neurourol Urodyn; 2016 Jun; 35(5):609-14. PubMed ID: 25914337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Efficacy and Safety of Repeated Intravescial OnabotulinumtoxinA Injections Plus Hydrodistention in the Treatment of Interstitial Cystitis/Bladder Pain Syndrome.
    Lee CL; Kuo HC
    Toxins (Basel); 2015 Oct; 7(10):4283-93. PubMed ID: 26506388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravesical Botulinum Toxin Injection Plus Hydrodistention Is More Effective in Patients with Bladder Pain-Predominant Interstitial Cystitis/Bladder Pain Syndrome.
    Yu WR; Jhang JF; Kuo HC
    Toxins (Basel); 2024 Feb; 16(2):. PubMed ID: 38393152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. O'Leary-Sant Symptom Index Predicts the Treatment Outcome for OnabotulinumtoxinA Injections for Refractory Interstitial Cystitis/Bladder Pain Syndrome.
    Kuo YC; Kuo HC
    Toxins (Basel); 2015 Jul; 7(8):2860-71. PubMed ID: 26264022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse Events of Intravesical OnabotulinumtoxinA Injection between Patients with Overactive Bladder and Interstitial Cystitis--Different Mechanisms of Action of Botox on Bladder Dysfunction?
    Kuo YC; Kuo HC
    Toxins (Basel); 2016 Mar; 8(3):. PubMed ID: 26999201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive Factors for a Satisfactory Treatment Outcome with Intravesical Botulinum Toxin A Injection in Patients with Interstitial Cystitis/Bladder Pain Syndrome.
    Wang HJ; Yu WR; Ong HL; Kuo HC
    Toxins (Basel); 2019 Nov; 11(11):. PubMed ID: 31752328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis/painful bladder syndrome.
    Kuo HC; Chancellor MB
    BJU Int; 2009 Sep; 104(5):657-61. PubMed ID: 19338543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment Outcomes of Intravesical Botulinum Toxin A Injections on Patients with Interstitial Cystitis/Bladder Pain Syndrome.
    Yu WR; Jiang YH; Jhang JF; Chang WC; Kuo HC
    Toxins (Basel); 2022 Dec; 14(12):. PubMed ID: 36548768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated intravesical injections of platelet-rich plasma improve symptoms and alter urinary functional proteins in patients with refractory interstitial cystitis.
    Jiang YH; Kuo YC; Jhang JF; Lee CL; Hsu YH; Ho HC; Kuo HC
    Sci Rep; 2020 Sep; 10(1):15218. PubMed ID: 32939046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How Intravesical Platelet-Rich Plasma Can Help Patients with Interstitial Cystitis/Bladder Pain Syndrome: A Comprehensive Scoping Review.
    Soliman A; Adel M; Elnagar MA; Elsonbaty S; Hefnawy AE
    Int Urogynecol J; 2024 Sep; 35(9):1735-1743. PubMed ID: 38958727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of onabotulinum toxin-A injection on sexual function in women with refractory interstitial cystitis/bladder pain syndrome: A prospective study.
    Karaburun MC; Kubilay E; Öztuna D; Gökçe Mİ; Süer E; Gülpınar Ö
    Low Urin Tract Symptoms; 2024 Mar; 16(2):e12511. PubMed ID: 38527461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.